Endpoints News 5 déc. 2025 OTR Therapeutics gets $100M from Pfizer Ventures, others to build asset portfolio
FierceBiotech 5 déc. 2025 Pfizer Ventures gets behind Chinese biotech's $100M series A to boost R&D hub's capability
Endpoints News 4 déc. 2025 Daiichi Sankyo avoids payout in long-running patent dispute with Pfizer’s Seagen
FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/biotech/pfizer-details-phase-3-data-mrna-flu-vaccine" hreflang="en">Pfizer's mRNA flu vaccine shows 34.5% greater efficacy than standard shot in phase 3</a> #mRNA flu #Pfizer mRNA